456 A randomized double-blind trial in 813 previously untreated metastatic prostate cancer (CaP) patients (PTS) comparing a new antiandrogen casodex® (bicalutamide) with eulexin (flutamide) in combination with luteinizing hormone releasing hormone analogue (LHRH-a) therapy

✍ Scribed by N.J. Vogelzang; P.F. Schellhammer; R. Sharifi; N.L. Block; M.S. Soloway; P.M. Venner; A.L. Patterson; M.F. Sarosdy; J.A. Jones; G. Kolvenbag

• Book ID: 116167210
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 137 KB
• Volume: 31
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(95)95710-n